Your browser doesn't support javascript.
loading
Treatment Switch to Dolutegravir With 2 Nucleoside Reverse-Transcriptase Inhibitors (NRTI) in Comparison to Continuation With Protease Inhibitor/Ritonavir Among Patients With Human Immunodeficiency Virus at Risk for Prior NRTI Resistance: A Cohort Analysis of Real-World Data.
Sangaré, Mohamed N'dongo; Baril, Jean-Guy; de Pokomandy, Alexandra; Ferreira Guerra, Steve; Carabali, Mabel; Laprise, Claudie; Thomas, Réjean; Klein, Marina; Tremblay, Cécile; Roger, Michel; Pexos, Costa; Greenwald, Zoë R; Machouf, Nima; Durand, Madeleine; Hardy, Isabelle; Dakouo, Mamadou; Trevisan, Andrea; Laporte, Louise; Schnitzer, Mireille E; Trottier, Helen.
Afiliação
  • Sangaré MN; Department of Social and Preventive Medicine, Université de Montréal, Montreal, Québec, Canada.
  • Baril JG; Sainte Justine University Hospital Center, Montreal, Québec, Canada.
  • de Pokomandy A; Clinique de Médecine Urbaine du Quartier Latin, Montreal, Québec, Canada.
  • Ferreira Guerra S; Faculty of Medicine, Université de Montréal Montreal, Québec, Canada.
  • Carabali M; Centre Hospitalier de l'Université de Montréal Montreal, Québec, Canada.
  • Laprise C; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Québec, Canada.
  • Thomas R; Department of Family Medicine, Faculty of Medicine, McGill University, Montreal, Québec, Canada.
  • Klein M; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, Canada.
  • Tremblay C; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Québec, Canada.
  • Roger M; Division of Oral Health and Society, McGill University, Montreal, Québec, Canada.
  • Pexos C; Clinique Médicale L'Actuel, Montreal, Québec, Canada.
  • Greenwald ZR; Chronic Viral Illness Service, McGill University Health Centre, Montreal, Québec, Canada.
  • Machouf N; Faculty of Medicine, Université de Montréal Montreal, Québec, Canada.
  • Durand M; Centre Hospitalier de l'Université de Montréal Montreal, Québec, Canada.
  • Hardy I; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Dakouo M; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, Québec, Canada.
  • Trevisan A; Faculty of Medicine, Université de Montréal Montreal, Québec, Canada.
  • Laporte L; Centre Hospitalier de l'Université de Montréal Montreal, Québec, Canada.
  • Schnitzer ME; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
  • Trottier H; Department of Microbiology, Infectious Diseases and Immunology, Université de Montréal, Montreal, Québec, Canada.
Open Forum Infect Dis ; 7(11): ofaa404, 2020 Nov.
Article em En | MEDLINE | ID: mdl-33204746
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Canadá